- Comparison of Lansoprazole and Omeprazole in Therapy for Helicobacter pylori Infection
-
Shin SK, Lee YC, Youn YH, Na HG, Kim DY, Moon BS, Kim WH, Chon CY, Moon YM, Kang JK, Park IS
- KMID: 1857605
- Korean J Gastroenterol.
- 2000 Jun;35(6):716-723.
BACKGROUND/AIMS: The effectiveness of curative therapy for Helicobacter pylori (H. pylori) infection may vary according to the eradication rate, side effects, and compliance of regimen. Lansoprazole, one of proton-pump inhibitor,... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Single-Dose vs. Divided-Dose Drug Administration on Eradication of Helicobacter pylori in Patients with Peptic Ulcers
-
Park S, Cho SH, Choi KY, Chung IS, Chung KW, Sun HS, Park DH
- KMID: 2304623
- Korean J Gastroenterol.
- 2000 Jan;35(1):23-31.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Anaphylaxis to lansoprazole with tolerance to other proton pump inhibitors
-
Park IY, Do BJ, Ahn JS, Lee JH, Lee GY, Kim S, Choi JH
- KMID: 1803547
- Allergy Asthma Respir Dis.
- 2014 Nov;2(5):383-386.
- doi: 10.4168/aard.2014.2.5.383
Anaphylaxis to proton pump inhibitors (PPIs) has rarely been reported. Different patterns of cross-reactivity between PPIs have also been demonstrated using skin tests. Here, we report a case of anaphylaxis... -
- CITED
-
- Close
- SHARE
-
- Close
- Eradication Rate of Lansoprazole-Based Triple Therapy in Peptic Ulcer Patients with Helicobacter pylori and Efficacy of Urea Breath Test in Evaluating Helicobater pylori Eradication
-
Jung HK, Jin KJ, You MA, Bae KS, Kwon JM, Lee JS, Kim DY, Moon IH
- KMID: 1615184
- Infect Chemother.
- 2003 Jun;35(3):154-159.
BACKGROUND: There are only a few studies on Helicobacter pylori (H. pylori) for its eradication rates of lansoprazole-based triple therapy in Korea, and the results are controversial. Therefore, we undertook... -
- CITED
-
- Close
- SHARE
-
- Close
- The Therapeutic Effect of Triple Therapy in Helicobacter pylori Infection
-
Kim BS, Chung IS, Park DH, Yang YS, Lee DS, Kim SW, Byun BH, Choi JY
- KMID: 2240605
- Korean J Gastroenterol.
- 1998 Jul;32(1):32-37.
BACKGROUND AND AIMS: Helicobacter pylori infection is associated with chronic active gastritis, duodenal and gastric ulcers, gastric adenocarcinoma, and gastric lymphoma. Today, eradication of H. pylori represent a generally accepted... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of Long-Term Proton Pump Inhibitor Therapy on Gut Microbiota in F344 Rats: Pilot Study
-
Shin CM, Kim N, Kim YS, Nam RH, Park JH, Lee DH, Seok YJ, Kim YR, Kim JH, Kim JM, Kim JS, Jung HC
- KMID: 2412094
- Gut Liver.
- 2016 Nov;10(6):896-901.
- doi: 10.5009/gnl15529
BACKGROUND/AIMS: To evaluate changes in gut microbiota composition following long-term proton pump inhibitor (PPI) treatment. METHODS: Twenty-four-week-old F344 rats were fed diets with (n=6) or without (n=5) lansoprazole for 50 weeks.... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of a Proton Pump Inhibitor on Tumor Bleeding Prevention in Unresectable Gastric Cancer Patients: a Double-Blind, Randomized, Placebo-Controlled Trial
-
Kim YI, Kim MJ, Park SR, Kim HK, Cho SJ, Lee JY, Kim CG, Kim GH, Park MI, Nam BH, Park YI, Choi IJ
- KMID: 2383735
- J Gastric Cancer.
- 2017 Jun;17(2):120-131.
- doi: 10.5230/jgc.2017.17.e15
PURPOSE: Tumor bleeding is a major complication in inoperable gastric cancer. The study aim was to investigate the effects of proton pump inhibitor (PPI) treatment for the prevention of gastric... -
- CITED
-
- Close
- SHARE
-
- Close
- Ten Day Concomitant Therapy Is Superior to Ten Day Sequential Therapy for Helicobacter pylori Eradication
-
Kim SY, Park DK, Kwon KA, Kim KO, Kim YJ, Chung JW
- KMID: 2164428
- Korean J Gastroenterol.
- 2014 Nov;64(5):260-267.
- doi: 10.4166/kjg.2014.64.5.260
BACKGROUND/AIMS: Because the efficacy of standard triple therapy for Helicobacter pylori eradication has declined, new regimens such as sequential therapy (ST) and concomitant therapy (CoCTx) have been introduced. The aim... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison between Intravenous Pantoprazole and Oral Lansoprazole about the Prevention against Bleeding after Endoscopic Submucosal Dissection
-
Lee CG, Hahn SJ, Lim YJ, Kang HW, Kim JH, Lee JK, Koh MS, Lee JH, Yang CH
- KMID: 2249458
- Korean J Helicobacter Up Gastrointest Res.
- 2014 Jun;14(2):103-107.
- doi: 10.7704/kjhugr.2014.14.2.103
BACKGROUND/AIMS: Proton pump inhibitor (PPI) is generally prescribed to prevent post endoscopic submucosal dissection (ESD) bleeding. However, there was no consensus about the effectiveness of intravenous (IV) or oral PPI.... -
- CITED
-
- Close
- SHARE
-
- Close
- Induced Hypergastrinemia Can Prevent the Pancreatic Atrophy after Pancreatoduodenectomy in Human
-
Jang JY, Kim SW, Han JK, Park SJ, Park YC, Park YH
- KMID: 2209426
- J Korean Surg Soc.
- 2001 Jul;61(1):95-104.
PURPOSE: Following a pancreatoduodenectomy, atrophy of the distal pancreas commonly occurs. It has been demonstrated that gastrin stimulates the regeneration of the pancreas in animals. This study was undertaken to... -
- CITED
-
- Close
- SHARE
-
- Close
- Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in Korea
-
Kim BJ, Lee H, Lee YC, Jeon SW, Kim GH, Kim HS, Sung JK, Lee DH, Kim HU, Park MI, Choi IJ, Yoon SM, Kim SW, Baik GH, Lee JY, Kim JI, Kim SG, Kim J, Lee J, Kim JG, Kim JJ, Korean College of Helicobacter and Upper Gastrointestinal Research
- KMID: 2458510
- Gut Liver.
- 2019 Sep;13(5):531-540.
- doi: 10.5009/gnl19136
BACKGROUND/AIMS: This nationwide, multicenter prospective randomized controlled trial aimed to compare the efficacy and safety of 10-day concomitant therapy (CT) and 10-day sequential therapy (ST) with 7-day clarithromycin-containing triple therapy... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison on Oral versus Intravenous Proton Pump Inhibitors for Prevention of Bleeding after Endoscopic Submucosal Dissection of Gastric Lesions
-
Jung YS, Kim KO, Lee SH, Jang BI, Kim TN
- KMID: 2383544
- Korean J Gastroenterol.
- 2016 Feb;67(2):74-80.
- doi: 10.4166/kjg.2016.67.2.74
BACKGROUND/AIMS: Although intravenous proton pump inhibitor (PPI) has been used for the prevention of post endoscopic submucosal dissection (ESD) bleeding, the route of administration has not been confirmed. The aim... -
- CITED
-
- Close
- SHARE
-
- Close
- Cost-effectiveness analysis of proton pump inhibitors and ranitidine in the treatment of gastroesophageal reflux disease
-
Yun HR, Jung HY, Park HJ, Bae SC
- KMID: 1866911
- Korean J Med.
- 2002 May;62(5):504-512.
BACKGROUND: The aim of this study was to compare the cost-effectiveness of proton pump inhibitors (PPI) and ranitidine in gastroesophageal reflux disease (GERD) in Korea. METHODS: We assessed the cost-effectiveness two... -
- CITED
-
- Close
- SHARE
-
- Close
- The Efficacy of Rebamipide or Ecabet Sodium Supplementation for Helicobacter pylori Eradication Therapy Compared with Quadruple (Concomitant) Regimen
-
Kim J, Kim K, Lee JS, Kim SY, Kim KO, Kim YJ, Kwon KA, Park DK, Chung JW
- KMID: 2409889
- Korean J Gastroenterol.
- 2018 Apr;71(4):204-212.
- doi: 10.4166/kjg.2018.71.4.204
BACKGROUND/AIMS: Although some previous studies reported that a treatment combined with mucoprotective agent could improve the eradication rate in dual or triple therapy, there are other reports that question the... -
- CITED
-
- Close
- SHARE
-
- Close
